查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1643510

病人参与人工智慧的全球市场

Artificial Intelligence in Patient Engagement
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 248 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年，全球病人参与人工智慧市场规模预计将达到 231 亿美元

2024 年全球人工智慧患者病人参与市场规模估计为 80 亿美元，预计到 2030 年将达到 231 亿美元，2024 年至 2030 年的复合年增长率为 19.4%。云端基础的交付模式是报告中分析的细分市场之一，预计到分析期结束时复合年增长率将达到 21.7%，达到 184 亿美元。在分析期间内，现场交付模式部分的复合年增长率预计为 12.8%。

美国市场预计将达到 21 亿美元，中国市场年复合成长率将达到 18.3%

预计到 2024 年，美国病人参与人工智慧市场规模将达到 21 亿美元。中国是世界第二大经济体，预计到 2030 年市场规模将达到 35 亿美元，2024-2030 年分析期间的复合年增长率为 18.3%。其他值得注意的区域市场包括日本和加拿大，预计在分析期间的复合年增长率分别为 18.0% 和 16.4%。在欧洲，预计德国的复合年增长率约为 13.0%。

全球病人参与人工智慧市场 - 主要趋势和驱动因素摘要

人工智慧将如何改变病人参与？

人工智慧 (AI) 透过提供个人化护理、改善沟通以及让患者积极参与管理自己的健康，彻底改变了病人参与。传统的病人参与方法通常依赖手动互动和标准化方法，无法有效满足个人需求。人工智慧利用机器学习 (ML)、自然语言处理 (NLP) 和预测分析来提供个人化和有意义的患者体验，从而解决这些挑战。

人工智慧聊天机器人和虚拟助理提供全天候支持，回答患者的疑问、安排预约、发送药物提醒等。这些工具提高了可近性，同时减轻了医疗保健提供者的管理负担。此外，人工智慧系统可以分析患者资料并提供个人化的健康提案，确保参与策略符合个人偏好和病历。

此外，人工智慧还将透过行动应用程式、入口网站和穿戴式装置提供客製化内容，加强对患者的教育。这些平台提供有关健康状况、治疗方案和生活方式改变的见解，以促进明智的决策。透过实现持续的、情境感知的参与，人工智慧正在改变患者与医疗服务互动的方式。

推动人工智慧在病人参与的应用的因素有哪些？

对个人化和高效医疗保健体验的需求日益增长，是推动病人参与采用人工智慧的主要驱动力。随着患者越来越要求满足其独特需求的客製化护理，人工智慧解决方案提供客製化的沟通和支持，以提高满意度和治疗效果。这些工具可以满足不同患者的偏好，从数位技术娴熟的患者到需要更多指导的患者。

远端医疗和远距会诊模式的兴起也刺激了人工智慧的采用。随着虚拟访问变得越来越普遍，人工智慧主导的平台透过为患者提供自我监测、症状追踪和虚拟跟进的工具来填补这一空白。这些能力可以确保护理的连续性，同时改善偏远和服务不足地区患者的治疗机会。

此外，资料整合和互通性的进步使得人工智慧系统能够跨多个接触点提供无缝的病人参与。透过分析电子健康记录(EHR)、穿戴式装置和健康应用程式的资料，AI 可以建立患者病人历程的统一视图，以提供一致、有影响力的互动。这些趋势强调了人工智慧在重塑病人参与策略方面日益增长的重要性。

人工智慧可以改善健康结果和患者满意度吗？

透过提供主动、个人化的护理，人工智慧正在显着改善健康结果和患者满意度。预测分析工具可以识别患有慢性疾病和併发症风险的患者，以便及时介入并降低住院的可能性。例如，人工智慧系统可以监测生命征象和生活方式资料，以检测糖尿病和心臟病等疾病的早期预警讯号，使医疗保健提供者能够采取预防措施。

透过自动化日常任务和改善护理协调，人工智慧减少了常常导致患者不满的管理效率低下。即时更新、自动预约提醒以及轻鬆存取医疗资讯让患者随时了解情况并参与护理。这些功能改善了患者的整体体验并提高了治疗计划的依从性。

人工智慧还可以透过提供压力管理、正念和行为疗法工具来支持心理健康和福祉。虚拟助理解决患者照护的情感方面的问题，提供个人化的建议和应对策略。这些技术创新有助于整体医疗保健并改善身心健康。

是什么推动了病人参与市场人工智慧的成长？

病人参与市场中人工智慧的成长受到几个关键因素的推动，这些因素反映了其在医疗保健领域的变革潜力。对以患者为中心的护理模式的日益关注，促使医疗保健提供者采用人工智慧工具来改善沟通并提供个人化的体验。这些解决方案可协助组织与患者建立更牢固的关係，提高忠诚度和信任度。

人工智慧的技术进步，包括机器学习、NLP 和即时分析，正在扩展病人参与平台的功能。这些工具提供可操作的见解，使医疗保健提供者能够预测患者的需求并提供主动支援。

消费者行为趋势，例如对数位健康解决方案的偏好日益增长，正在进一步推动市场成长。患者正在使用行动应用程式、穿戴式装置和虚拟助理作为有效管理健康的工具。此外，促进基于价值的护理和病人参与倡议的监管奖励正在推动人工智慧在医疗保健领域的应用。

这些因素，加上对数位健康技术不断增加的投资，正在推动人工智慧市场在病人参与的快速扩张，并将其定位为未来医疗保健服务和以患者为中心的服务创新的基石。

部分

交付格式（云端基础的交付格式、本地交付格式）、功能（增强通讯功能、聊天机器人和虚拟健康助理功能、预测分析功能、病患教育功能、其他功能）、技术（自然语言处理（NLP 技术、其他技术）、治疗领域（慢性病管理治疗领域、健康与保健治疗领域、其他治疗领域）、最终用户（医疗服务提供者最终用户、医疗服务付款人最终用户、其他最终用户）

受访公司范例（52家值得关注的公司）

  • Ada Health GmbH
  • AiCure
  • Aiva
  • AllazoHealth
  • Brand Engagement Network, Inc.
  • Claritas Rx
  • EmpiRx Health, LLC.
  • Health Catalyst
  • Huma
  • IBM Corporation

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章 市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲国家
  • 亚太地区
  • 其他地区

第四章 竞赛

简介目录
Product Code: MCP29263

Global Artificial Intelligence in Patient Engagement Market to Reach US$23.1 Billion by 2030

The global market for Artificial Intelligence in Patient Engagement estimated at US$8.0 Billion in the year 2024, is expected to reach US$23.1 Billion by 2030, growing at a CAGR of 19.4% over the analysis period 2024-2030. Cloud-based Delivery Mode, one of the segments analyzed in the report, is expected to record a 21.7% CAGR and reach US$18.4 Billion by the end of the analysis period. Growth in the On-Premise Delivery Mode segment is estimated at 12.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.1 Billion While China is Forecast to Grow at 18.3% CAGR

The Artificial Intelligence in Patient Engagement market in the U.S. is estimated at US$2.1 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$3.5 Billion by the year 2030 trailing a CAGR of 18.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 18.0% and 16.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 13.0% CAGR.

Global Artificial Intelligence in Patient Engagement Market - Key Trends & Drivers Summarized

How Is AI Transforming Patient Engagement?

Artificial Intelligence (AI) is revolutionizing patient engagement by delivering personalized care, improving communication, and empowering patients to take an active role in their health management. Traditional patient engagement methods often rely on manual interactions and standardized approaches that fail to address individual needs effectively. AI addresses these challenges by leveraging machine learning (ML), natural language processing (NLP), and predictive analytics to create tailored and meaningful patient experiences.

AI-powered chatbots and virtual assistants provide 24/7 support, answering patient queries, scheduling appointments, and sending medication reminders. These tools enhance accessibility while reducing the administrative burden on healthcare providers. In addition, AI systems analyze patient data to offer personalized health recommendations, ensuring that engagement strategies align with individual preferences and medical histories.

Moreover, AI enhances patient education by delivering customized content through mobile apps, portals, and wearable devices. These platforms provide insights into health conditions, treatment options, and lifestyle changes, fostering informed decision-making. By enabling continuous and context-aware engagement, AI is transforming the way patients interact with healthcare services.

What Drives the Adoption of AI in Patient Engagement?

The growing demand for personalized and efficient healthcare experiences is a major driver of AI adoption in patient engagement. As patients increasingly seek customized care that addresses their unique needs, AI-powered solutions offer tailored communication and support that enhances satisfaction and outcomes. These tools cater to diverse patient preferences, from digital-savvy individuals to those requiring more guidance.

The rise of telemedicine and remote care models is also fueling AI adoption. With virtual consultations becoming more prevalent, AI-driven platforms bridge the gap by providing patients with tools for self-monitoring, symptom tracking, and virtual follow-ups. These capabilities ensure continuity of care while improving access for patients in remote or underserved areas.

Additionally, advancements in data integration and interoperability are enabling AI systems to provide seamless patient engagement across multiple touchpoints. By analyzing data from electronic health records (EHRs), wearable devices, and health apps, AI creates a unified view of the patient journey, ensuring consistent and impactful interactions. These trends underscore the growing importance of AI in reshaping patient engagement strategies.

Can AI Enhance Health Outcomes and Patient Satisfaction?

AI is significantly enhancing health outcomes and patient satisfaction by fostering proactive and personalized care. Predictive analytics tools identify patients at risk of chronic conditions or complications, enabling timely interventions and reducing the likelihood of hospitalizations. For example, AI systems monitor vital signs and lifestyle data to detect early warning signs of conditions such as diabetes or heart disease, allowing healthcare providers to take preventive action.

By automating routine tasks and improving care coordination, AI reduces administrative inefficiencies that often lead to patient dissatisfaction. Real-time updates, automated appointment reminders, and easy access to medical information empower patients to stay informed and engaged in their care. These capabilities enhance the overall patient experience while ensuring better adherence to treatment plans.

AI also supports mental health and well-being by providing tools for stress management, mindfulness, and behavioral therapy. Virtual mental health assistants deliver personalized recommendations and coping strategies, addressing the emotional aspects of patient care. These innovations contribute to holistic health management, improving both physical and mental well-being.

What’s Driving the Growth of the AI in Patient Engagement Market?

The growth in the Artificial Intelligence in Patient Engagement market is driven by several critical factors, reflecting its transformative potential in healthcare. The increasing focus on patient-centric care models is encouraging healthcare providers to adopt AI tools that improve communication and deliver personalized experiences. These solutions help organizations build stronger relationships with patients, enhancing loyalty and trust.

Technological advancements in AI, including machine learning, NLP, and real-time analytics, are expanding the capabilities of patient engagement platforms. These tools provide actionable insights that enable healthcare providers to anticipate patient needs and deliver proactive support.

Consumer behavior trends, such as the growing preference for digital health solutions, are further driving market growth. Patients are embracing mobile apps, wearable devices, and virtual assistants as tools to manage their health effectively. Additionally, regulatory incentives promoting value-based care and patient engagement initiatives are supporting the adoption of AI in healthcare.

These factors, coupled with increasing investments in digital health technologies, are propelling the rapid expansion of the AI in Patient Engagement market, positioning it as a cornerstone of future innovation in healthcare delivery and patient-centric services.

SCOPE OF STUDY:

The report analyzes the Artificial Intelligence in Patient Engagement market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Delivery Mode (Cloud-based Delivery Mode, On-Premise Delivery Mode); Functionality (Enhanced Communication Functionality, Chatbots & Virtual Health Assistants Functionality, Predictive Analytics Functionality, Patient Education Functionality, Other Functionalities); Technology (Natural Language Processing (NLP) Technology, Other Technologies); Therapeutic Area (Chronic Disease Management Therapeutic Area, Health & Wellness Therapeutic Area, Other Therapeutic Areas); End-Use (Healthcare Providers End-Use, Healthcare Payers End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 52 Featured) -

  • Ada Health GmbH
  • AiCure
  • Aiva
  • AllazoHealth
  • Brand Engagement Network, Inc.
  • Claritas Rx
  • EmpiRx Health, LLC.
  • Health Catalyst
  • Huma
  • IBM Corporation

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Economic Frontiers: Trends, Trials & Transformations
    • Artificial Intelligence in Patient Engagement - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Real-Time AI Chatbots Expand Opportunities for Enhancing Patient Communication
    • AI for Personalized Health Recommendations Strengthens Case for Proactive Engagement
    • AI-Driven Virtual Health Assistants Spur Growth in Home-Based Care Models
    • AI for Appointment Scheduling Optimizes Patient Flow, Driving Market Adoption
    • AI in Medication Adherence Monitoring Highlights Opportunities in Chronic Disease Management
    • AI-Powered Health Education Platforms Expand Addressable Market for Wellness Apps
    • Growing Demand for AI in Telehealth Sets the Stage for Patient-Centric Engagement Tools
    • AI for Remote Monitoring Systems Strengthens Case for Continuous Patient Interaction
    • AI for Multilingual Support Tools Bodes Well for Global Patient Engagement Markets
    • Integration of AI in Family Health Management Strengthens Use Cases in Collaborative Care
    • AI for Seamless Billing and Insurance Queries Drives Adoption in Revenue Cycle Management
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Artificial Intelligence in Patient Engagement Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Artificial Intelligence in Patient Engagement by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Cloud-based Delivery Mode by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Cloud-based Delivery Mode by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for On-Premise Delivery Mode by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for On-Premise Delivery Mode by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Chronic Disease Management Therapeutic Area by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Chronic Disease Management Therapeutic Area by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Health & Wellness Therapeutic Area by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Health & Wellness Therapeutic Area by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Other Therapeutic Areas by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Other Therapeutic Areas by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Healthcare Providers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Healthcare Providers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Healthcare Payers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Healthcare Payers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 19: World 6-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Enhanced Communication Functionality by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World 6-Year Perspective for Enhanced Communication Functionality by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Chatbots & Virtual Health Assistants Functionality by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 23: World 6-Year Perspective for Chatbots & Virtual Health Assistants Functionality by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 24: World Recent Past, Current & Future Analysis for Predictive Analytics Functionality by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 25: World 6-Year Perspective for Predictive Analytics Functionality by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Patient Education Functionality by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World 6-Year Perspective for Patient Education Functionality by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Other Functionalities by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 29: World 6-Year Perspective for Other Functionalities by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 30: World Recent Past, Current & Future Analysis for Natural Language Processing (NLP) Technology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 31: World 6-Year Perspective for Natural Language Processing (NLP) Technology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 33: World 6-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Artificial Intelligence in Patient Engagement Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 34: USA Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Delivery mode - Cloud-based Delivery Mode and On-Premise Delivery Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 35: USA 6-Year Perspective for Artificial Intelligence in Patient Engagement by Delivery mode - Percentage Breakdown of Value Sales for Cloud-based Delivery Mode and On-Premise Delivery Mode for the Years 2025 & 2030
    • TABLE 36: USA Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Therapeutic Area - Chronic Disease Management Therapeutic Area, Health & Wellness Therapeutic Area and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 37: USA 6-Year Perspective for Artificial Intelligence in Patient Engagement by Therapeutic Area - Percentage Breakdown of Value Sales for Chronic Disease Management Therapeutic Area, Health & Wellness Therapeutic Area and Other Therapeutic Areas for the Years 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by End-Use - Healthcare Providers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA 6-Year Perspective for Artificial Intelligence in Patient Engagement by End-Use - Percentage Breakdown of Value Sales for Healthcare Providers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 40: USA Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Functionality - Enhanced Communication Functionality, Chatbots & Virtual Health Assistants Functionality, Predictive Analytics Functionality, Patient Education Functionality and Other Functionalities - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 41: USA 6-Year Perspective for Artificial Intelligence in Patient Engagement by Functionality - Percentage Breakdown of Value Sales for Enhanced Communication Functionality, Chatbots & Virtual Health Assistants Functionality, Predictive Analytics Functionality, Patient Education Functionality and Other Functionalities for the Years 2025 & 2030
    • TABLE 42: USA Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Technology - Natural Language Processing (NLP) Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 43: USA 6-Year Perspective for Artificial Intelligence in Patient Engagement by Technology - Percentage Breakdown of Value Sales for Natural Language Processing (NLP) Technology and Other Technologies for the Years 2025 & 2030
  • CANADA
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Delivery mode - Cloud-based Delivery Mode and On-Premise Delivery Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada 6-Year Perspective for Artificial Intelligence in Patient Engagement by Delivery mode - Percentage Breakdown of Value Sales for Cloud-based Delivery Mode and On-Premise Delivery Mode for the Years 2025 & 2030
    • TABLE 46: Canada Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Therapeutic Area - Chronic Disease Management Therapeutic Area, Health & Wellness Therapeutic Area and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 47: Canada 6-Year Perspective for Artificial Intelligence in Patient Engagement by Therapeutic Area - Percentage Breakdown of Value Sales for Chronic Disease Management Therapeutic Area, Health & Wellness Therapeutic Area and Other Therapeutic Areas for the Years 2025 & 2030
    • TABLE 48: Canada Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by End-Use - Healthcare Providers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 49: Canada 6-Year Perspective for Artificial Intelligence in Patient Engagement by End-Use - Percentage Breakdown of Value Sales for Healthcare Providers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Functionality - Enhanced Communication Functionality, Chatbots & Virtual Health Assistants Functionality, Predictive Analytics Functionality, Patient Education Functionality and Other Functionalities - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada 6-Year Perspective for Artificial Intelligence in Patient Engagement by Functionality - Percentage Breakdown of Value Sales for Enhanced Communication Functionality, Chatbots & Virtual Health Assistants Functionality, Predictive Analytics Functionality, Patient Education Functionality and Other Functionalities for the Years 2025 & 2030
    • TABLE 52: Canada Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Technology - Natural Language Processing (NLP) Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 53: Canada 6-Year Perspective for Artificial Intelligence in Patient Engagement by Technology - Percentage Breakdown of Value Sales for Natural Language Processing (NLP) Technology and Other Technologies for the Years 2025 & 2030
  • JAPAN
    • Artificial Intelligence in Patient Engagement Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 54: Japan Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Delivery mode - Cloud-based Delivery Mode and On-Premise Delivery Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 55: Japan 6-Year Perspective for Artificial Intelligence in Patient Engagement by Delivery mode - Percentage Breakdown of Value Sales for Cloud-based Delivery Mode and On-Premise Delivery Mode for the Years 2025 & 2030
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Therapeutic Area - Chronic Disease Management Therapeutic Area, Health & Wellness Therapeutic Area and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan 6-Year Perspective for Artificial Intelligence in Patient Engagement by Therapeutic Area - Percentage Breakdown of Value Sales for Chronic Disease Management Therapeutic Area, Health & Wellness Therapeutic Area and Other Therapeutic Areas for the Years 2025 & 2030
    • TABLE 58: Japan Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by End-Use - Healthcare Providers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 59: Japan 6-Year Perspective for Artificial Intelligence in Patient Engagement by End-Use - Percentage Breakdown of Value Sales for Healthcare Providers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 60: Japan Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Functionality - Enhanced Communication Functionality, Chatbots & Virtual Health Assistants Functionality, Predictive Analytics Functionality, Patient Education Functionality and Other Functionalities - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 61: Japan 6-Year Perspective for Artificial Intelligence in Patient Engagement by Functionality - Percentage Breakdown of Value Sales for Enhanced Communication Functionality, Chatbots & Virtual Health Assistants Functionality, Predictive Analytics Functionality, Patient Education Functionality and Other Functionalities for the Years 2025 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Technology - Natural Language Processing (NLP) Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Japan 6-Year Perspective for Artificial Intelligence in Patient Engagement by Technology - Percentage Breakdown of Value Sales for Natural Language Processing (NLP) Technology and Other Technologies for the Years 2025 & 2030
  • CHINA
    • Artificial Intelligence in Patient Engagement Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 64: China Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Delivery mode - Cloud-based Delivery Mode and On-Premise Delivery Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 65: China 6-Year Perspective for Artificial Intelligence in Patient Engagement by Delivery mode - Percentage Breakdown of Value Sales for Cloud-based Delivery Mode and On-Premise Delivery Mode for the Years 2025 & 2030
    • TABLE 66: China Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Therapeutic Area - Chronic Disease Management Therapeutic Area, Health & Wellness Therapeutic Area and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 67: China 6-Year Perspective for Artificial Intelligence in Patient Engagement by Therapeutic Area - Percentage Breakdown of Value Sales for Chronic Disease Management Therapeutic Area, Health & Wellness Therapeutic Area and Other Therapeutic Areas for the Years 2025 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by End-Use - Healthcare Providers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China 6-Year Perspective for Artificial Intelligence in Patient Engagement by End-Use - Percentage Breakdown of Value Sales for Healthcare Providers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 70: China Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Functionality - Enhanced Communication Functionality, Chatbots & Virtual Health Assistants Functionality, Predictive Analytics Functionality, Patient Education Functionality and Other Functionalities - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 71: China 6-Year Perspective for Artificial Intelligence in Patient Engagement by Functionality - Percentage Breakdown of Value Sales for Enhanced Communication Functionality, Chatbots & Virtual Health Assistants Functionality, Predictive Analytics Functionality, Patient Education Functionality and Other Functionalities for the Years 2025 & 2030
    • TABLE 72: China Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Technology - Natural Language Processing (NLP) Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 73: China 6-Year Perspective for Artificial Intelligence in Patient Engagement by Technology - Percentage Breakdown of Value Sales for Natural Language Processing (NLP) Technology and Other Technologies for the Years 2025 & 2030
  • EUROPE
    • Artificial Intelligence in Patient Engagement Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe 6-Year Perspective for Artificial Intelligence in Patient Engagement by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 76: Europe Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Delivery mode - Cloud-based Delivery Mode and On-Premise Delivery Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 77: Europe 6-Year Perspective for Artificial Intelligence in Patient Engagement by Delivery mode - Percentage Breakdown of Value Sales for Cloud-based Delivery Mode and On-Premise Delivery Mode for the Years 2025 & 2030
    • TABLE 78: Europe Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Therapeutic Area - Chronic Disease Management Therapeutic Area, Health & Wellness Therapeutic Area and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 79: Europe 6-Year Perspective for Artificial Intelligence in Patient Engagement by Therapeutic Area - Percentage Breakdown of Value Sales for Chronic Disease Management Therapeutic Area, Health & Wellness Therapeutic Area and Other Therapeutic Areas for the Years 2025 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by End-Use - Healthcare Providers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe 6-Year Perspective for Artificial Intelligence in Patient Engagement by End-Use - Percentage Breakdown of Value Sales for Healthcare Providers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 82: Europe Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Functionality - Enhanced Communication Functionality, Chatbots & Virtual Health Assistants Functionality, Predictive Analytics Functionality, Patient Education Functionality and Other Functionalities - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 83: Europe 6-Year Perspective for Artificial Intelligence in Patient Engagement by Functionality - Percentage Breakdown of Value Sales for Enhanced Communication Functionality, Chatbots & Virtual Health Assistants Functionality, Predictive Analytics Functionality, Patient Education Functionality and Other Functionalities for the Years 2025 & 2030
    • TABLE 84: Europe Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Technology - Natural Language Processing (NLP) Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 85: Europe 6-Year Perspective for Artificial Intelligence in Patient Engagement by Technology - Percentage Breakdown of Value Sales for Natural Language Processing (NLP) Technology and Other Technologies for the Years 2025 & 2030
  • FRANCE
    • Artificial Intelligence in Patient Engagement Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 86: France Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Delivery mode - Cloud-based Delivery Mode and On-Premise Delivery Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: France 6-Year Perspective for Artificial Intelligence in Patient Engagement by Delivery mode - Percentage Breakdown of Value Sales for Cloud-based Delivery Mode and On-Premise Delivery Mode for the Years 2025 & 2030
    • TABLE 88: France Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Therapeutic Area - Chronic Disease Management Therapeutic Area, Health & Wellness Therapeutic Area and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 89: France 6-Year Perspective for Artificial Intelligence in Patient Engagement by Therapeutic Area - Percentage Breakdown of Value Sales for Chronic Disease Management Therapeutic Area, Health & Wellness Therapeutic Area and Other Therapeutic Areas for the Years 2025 & 2030
    • TABLE 90: France Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by End-Use - Healthcare Providers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 91: France 6-Year Perspective for Artificial Intelligence in Patient Engagement by End-Use - Percentage Breakdown of Value Sales for Healthcare Providers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 92: France Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Functionality - Enhanced Communication Functionality, Chatbots & Virtual Health Assistants Functionality, Predictive Analytics Functionality, Patient Education Functionality and Other Functionalities - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: France 6-Year Perspective for Artificial Intelligence in Patient Engagement by Functionality - Percentage Breakdown of Value Sales for Enhanced Communication Functionality, Chatbots & Virtual Health Assistants Functionality, Predictive Analytics Functionality, Patient Education Functionality and Other Functionalities for the Years 2025 & 2030
    • TABLE 94: France Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Technology - Natural Language Processing (NLP) Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 95: France 6-Year Perspective for Artificial Intelligence in Patient Engagement by Technology - Percentage Breakdown of Value Sales for Natural Language Processing (NLP) Technology and Other Technologies for the Years 2025 & 2030
  • GERMANY
    • Artificial Intelligence in Patient Engagement Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 96: Germany Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Delivery mode - Cloud-based Delivery Mode and On-Premise Delivery Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 97: Germany 6-Year Perspective for Artificial Intelligence in Patient Engagement by Delivery mode - Percentage Breakdown of Value Sales for Cloud-based Delivery Mode and On-Premise Delivery Mode for the Years 2025 & 2030
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Therapeutic Area - Chronic Disease Management Therapeutic Area, Health & Wellness Therapeutic Area and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Germany 6-Year Perspective for Artificial Intelligence in Patient Engagement by Therapeutic Area - Percentage Breakdown of Value Sales for Chronic Disease Management Therapeutic Area, Health & Wellness Therapeutic Area and Other Therapeutic Areas for the Years 2025 & 2030
    • TABLE 100: Germany Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by End-Use - Healthcare Providers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 101: Germany 6-Year Perspective for Artificial Intelligence in Patient Engagement by End-Use - Percentage Breakdown of Value Sales for Healthcare Providers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 102: Germany Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Functionality - Enhanced Communication Functionality, Chatbots & Virtual Health Assistants Functionality, Predictive Analytics Functionality, Patient Education Functionality and Other Functionalities - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 103: Germany 6-Year Perspective for Artificial Intelligence in Patient Engagement by Functionality - Percentage Breakdown of Value Sales for Enhanced Communication Functionality, Chatbots & Virtual Health Assistants Functionality, Predictive Analytics Functionality, Patient Education Functionality and Other Functionalities for the Years 2025 & 2030
    • TABLE 104: Germany Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Technology - Natural Language Processing (NLP) Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Germany 6-Year Perspective for Artificial Intelligence in Patient Engagement by Technology - Percentage Breakdown of Value Sales for Natural Language Processing (NLP) Technology and Other Technologies for the Years 2025 & 2030
  • ITALY
    • TABLE 106: Italy Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Delivery mode - Cloud-based Delivery Mode and On-Premise Delivery Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 107: Italy 6-Year Perspective for Artificial Intelligence in Patient Engagement by Delivery mode - Percentage Breakdown of Value Sales for Cloud-based Delivery Mode and On-Premise Delivery Mode for the Years 2025 & 2030
    • TABLE 108: Italy Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Therapeutic Area - Chronic Disease Management Therapeutic Area, Health & Wellness Therapeutic Area and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 109: Italy 6-Year Perspective for Artificial Intelligence in Patient Engagement by Therapeutic Area - Percentage Breakdown of Value Sales for Chronic Disease Management Therapeutic Area, Health & Wellness Therapeutic Area and Other Therapeutic Areas for the Years 2025 & 2030
    • TABLE 110: Italy Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by End-Use - Healthcare Providers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Italy 6-Year Perspective for Artificial Intelligence in Patient Engagement by End-Use - Percentage Breakdown of Value Sales for Healthcare Providers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 112: Italy Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Functionality - Enhanced Communication Functionality, Chatbots & Virtual Health Assistants Functionality, Predictive Analytics Functionality, Patient Education Functionality and Other Functionalities - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 113: Italy 6-Year Perspective for Artificial Intelligence in Patient Engagement by Functionality - Percentage Breakdown of Value Sales for Enhanced Communication Functionality, Chatbots & Virtual Health Assistants Functionality, Predictive Analytics Functionality, Patient Education Functionality and Other Functionalities for the Years 2025 & 2030
    • TABLE 114: Italy Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Technology - Natural Language Processing (NLP) Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 115: Italy 6-Year Perspective for Artificial Intelligence in Patient Engagement by Technology - Percentage Breakdown of Value Sales for Natural Language Processing (NLP) Technology and Other Technologies for the Years 2025 & 2030
  • UNITED KINGDOM
    • Artificial Intelligence in Patient Engagement Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 116: UK Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Delivery mode - Cloud-based Delivery Mode and On-Premise Delivery Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: UK 6-Year Perspective for Artificial Intelligence in Patient Engagement by Delivery mode - Percentage Breakdown of Value Sales for Cloud-based Delivery Mode and On-Premise Delivery Mode for the Years 2025 & 2030
    • TABLE 118: UK Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Therapeutic Area - Chronic Disease Management Therapeutic Area, Health & Wellness Therapeutic Area and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 119: UK 6-Year Perspective for Artificial Intelligence in Patient Engagement by Therapeutic Area - Percentage Breakdown of Value Sales for Chronic Disease Management Therapeutic Area, Health & Wellness Therapeutic Area and Other Therapeutic Areas for the Years 2025 & 2030
    • TABLE 120: UK Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by End-Use - Healthcare Providers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 121: UK 6-Year Perspective for Artificial Intelligence in Patient Engagement by End-Use - Percentage Breakdown of Value Sales for Healthcare Providers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 122: UK Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Functionality - Enhanced Communication Functionality, Chatbots & Virtual Health Assistants Functionality, Predictive Analytics Functionality, Patient Education Functionality and Other Functionalities - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: UK 6-Year Perspective for Artificial Intelligence in Patient Engagement by Functionality - Percentage Breakdown of Value Sales for Enhanced Communication Functionality, Chatbots & Virtual Health Assistants Functionality, Predictive Analytics Functionality, Patient Education Functionality and Other Functionalities for the Years 2025 & 2030
    • TABLE 124: UK Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Technology - Natural Language Processing (NLP) Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 125: UK 6-Year Perspective for Artificial Intelligence in Patient Engagement by Technology - Percentage Breakdown of Value Sales for Natural Language Processing (NLP) Technology and Other Technologies for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 126: Rest of Europe Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Delivery mode - Cloud-based Delivery Mode and On-Premise Delivery Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 127: Rest of Europe 6-Year Perspective for Artificial Intelligence in Patient Engagement by Delivery mode - Percentage Breakdown of Value Sales for Cloud-based Delivery Mode and On-Premise Delivery Mode for the Years 2025 & 2030
    • TABLE 128: Rest of Europe Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Therapeutic Area - Chronic Disease Management Therapeutic Area, Health & Wellness Therapeutic Area and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Europe 6-Year Perspective for Artificial Intelligence in Patient Engagement by Therapeutic Area - Percentage Breakdown of Value Sales for Chronic Disease Management Therapeutic Area, Health & Wellness Therapeutic Area and Other Therapeutic Areas for the Years 2025 & 2030
    • TABLE 130: Rest of Europe Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by End-Use - Healthcare Providers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 131: Rest of Europe 6-Year Perspective for Artificial Intelligence in Patient Engagement by End-Use - Percentage Breakdown of Value Sales for Healthcare Providers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 132: Rest of Europe Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Functionality - Enhanced Communication Functionality, Chatbots & Virtual Health Assistants Functionality, Predictive Analytics Functionality, Patient Education Functionality and Other Functionalities - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 133: Rest of Europe 6-Year Perspective for Artificial Intelligence in Patient Engagement by Functionality - Percentage Breakdown of Value Sales for Enhanced Communication Functionality, Chatbots & Virtual Health Assistants Functionality, Predictive Analytics Functionality, Patient Education Functionality and Other Functionalities for the Years 2025 & 2030
    • TABLE 134: Rest of Europe Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Technology - Natural Language Processing (NLP) Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of Europe 6-Year Perspective for Artificial Intelligence in Patient Engagement by Technology - Percentage Breakdown of Value Sales for Natural Language Processing (NLP) Technology and Other Technologies for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Artificial Intelligence in Patient Engagement Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 136: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Delivery mode - Cloud-based Delivery Mode and On-Premise Delivery Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 137: Asia-Pacific 6-Year Perspective for Artificial Intelligence in Patient Engagement by Delivery mode - Percentage Breakdown of Value Sales for Cloud-based Delivery Mode and On-Premise Delivery Mode for the Years 2025 & 2030
    • TABLE 138: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Therapeutic Area - Chronic Disease Management Therapeutic Area, Health & Wellness Therapeutic Area and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 139: Asia-Pacific 6-Year Perspective for Artificial Intelligence in Patient Engagement by Therapeutic Area - Percentage Breakdown of Value Sales for Chronic Disease Management Therapeutic Area, Health & Wellness Therapeutic Area and Other Therapeutic Areas for the Years 2025 & 2030
    • TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by End-Use - Healthcare Providers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Asia-Pacific 6-Year Perspective for Artificial Intelligence in Patient Engagement by End-Use - Percentage Breakdown of Value Sales for Healthcare Providers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 142: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Functionality - Enhanced Communication Functionality, Chatbots & Virtual Health Assistants Functionality, Predictive Analytics Functionality, Patient Education Functionality and Other Functionalities - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 143: Asia-Pacific 6-Year Perspective for Artificial Intelligence in Patient Engagement by Functionality - Percentage Breakdown of Value Sales for Enhanced Communication Functionality, Chatbots & Virtual Health Assistants Functionality, Predictive Analytics Functionality, Patient Education Functionality and Other Functionalities for the Years 2025 & 2030
    • TABLE 144: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Technology - Natural Language Processing (NLP) Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 145: Asia-Pacific 6-Year Perspective for Artificial Intelligence in Patient Engagement by Technology - Percentage Breakdown of Value Sales for Natural Language Processing (NLP) Technology and Other Technologies for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 146: Rest of World Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Delivery mode - Cloud-based Delivery Mode and On-Premise Delivery Mode - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Rest of World 6-Year Perspective for Artificial Intelligence in Patient Engagement by Delivery mode - Percentage Breakdown of Value Sales for Cloud-based Delivery Mode and On-Premise Delivery Mode for the Years 2025 & 2030
    • TABLE 148: Rest of World Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Therapeutic Area - Chronic Disease Management Therapeutic Area, Health & Wellness Therapeutic Area and Other Therapeutic Areas - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 149: Rest of World 6-Year Perspective for Artificial Intelligence in Patient Engagement by Therapeutic Area - Percentage Breakdown of Value Sales for Chronic Disease Management Therapeutic Area, Health & Wellness Therapeutic Area and Other Therapeutic Areas for the Years 2025 & 2030
    • TABLE 150: Rest of World Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by End-Use - Healthcare Providers End-Use, Healthcare Payers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 151: Rest of World 6-Year Perspective for Artificial Intelligence in Patient Engagement by End-Use - Percentage Breakdown of Value Sales for Healthcare Providers End-Use, Healthcare Payers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 152: Rest of World Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Functionality - Enhanced Communication Functionality, Chatbots & Virtual Health Assistants Functionality, Predictive Analytics Functionality, Patient Education Functionality and Other Functionalities - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Rest of World 6-Year Perspective for Artificial Intelligence in Patient Engagement by Functionality - Percentage Breakdown of Value Sales for Enhanced Communication Functionality, Chatbots & Virtual Health Assistants Functionality, Predictive Analytics Functionality, Patient Education Functionality and Other Functionalities for the Years 2025 & 2030
    • TABLE 154: Rest of World Recent Past, Current & Future Analysis for Artificial Intelligence in Patient Engagement by Technology - Natural Language Processing (NLP) Technology and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 155: Rest of World 6-Year Perspective for Artificial Intelligence in Patient Engagement by Technology - Percentage Breakdown of Value Sales for Natural Language Processing (NLP) Technology and Other Technologies for the Years 2025 & 2030

IV. COMPETITION